Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Urologic Oncology|February 26, 2013
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer modelsTetsuo Fujita, Takefumi Satoh, Terry L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate CancerZhe Tang, Patrick G Pilié, Chuandong Geng, et al.
The Journal of Urology|September 28, 2002
The role of caveolin-1 in androgen insensitive prostate cancerVladimir Mouraviev, Likun Li, Salahaldin A Tahir, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2002
Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer modelMaria T Vlachaki, Andres Hernandez-Garcia, Michael Ittmann, et al.
Endocrine-Related Cancer|September 26, 2024
Body composition in recurrent prostate cancer and the role of steroidogenic genotypeNeha Venkatesh, Rebecca S Tidwell, Yao Yu, et al.
Urology|May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical TrialsAndrew Fang, Daniel E Frigo, Andrew Hahn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 21, 2015
Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort StudyJianhua Yin, Junxue Wang, Rui Pu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2015
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate CancersAna M Aparicio, Li Shen, Elsa Li Ning Tapia, et al.
Cell Reports|May 11, 2022
The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62Juan F Linares, Tania Cid-Diaz, Angeles Duran, et al.
JCO Oncology Practice|November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone TherapyNeha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
Pageof 16